GlassScriptPhysician profile
Jennifer Smart
NPI 1871770891
$6,840.46
in general payments reported to CMS, 2019-2025
34 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,916 · 2020: $1,336 · 2021: $2,300 · 2022: $499 · 2023: $335 · 2024: $264 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $789.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,085.58 | 2019-2025 | Rybelsus, Ozempic, Tresiba |
| Astrazeneca Pharmaceuticals LP | $689.47 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $651.70 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $557.19 | 2019-2022 | |
| Glaxosmithkline, LLC. | $493.87 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $369.12 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $312.87 | 2019-2022 | |
| Astellas Pharma US INC | $305.44 | 2019-2024 | Veozah |
| Abbvie INC. | $236.44 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $229.18 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $204.03 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $197.67 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $176.87 | 2020-2021 | |
| Pfizer INC. | $157.28 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $142.28 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $134.55 | 2019-2020 | |
| Amarin Pharma, INC. | $112.98 | 2019-2021 | |
| Dexcom, INC. | $102.50 | 2022-2025 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $102.28 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $69.04 | 2023-2024 | Quviviq |
| Arbor Pharmaceuticals, INC. | $68.80 | 2019-2020 | |
| Abbott Laboratories | $55.13 | 2019-2021 | |
| Eisai INC. | $55.02 | 2021 | |
| Daiichi Sankyo INC. | $52.94 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $41.65 | 2019-2020 | |
| Boston Scientific Corporation | $41.61 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.76 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $37.97 | 2020-2021 | |
| Axsome Therapeutics, INC. | $26.17 | 2024 | Auvelity |
| Philips North America LLC | $26.07 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $24.04 | 2020-2021 | |
| Exact Sciences Corporation | $16.00 | 2023 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $12.63 | 2019 | |
| Ironwood Pharmaceuticals, INC | $11.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Smart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.